<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Tobramycin</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00684</strong>&#160; (APRD00582)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the pseudomonas species. It is a 10% component of the antibiotic complex, nebramycin, produced by the same species. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00684/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00684/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00684.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00684.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00684.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00684.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00684.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00684">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>Nebramycin-Faktor 6</td><td><span class="wishart wishart-not-available">Not Available</span></td><td>IS</td></tr><tr><td>Tobramicina</td><td>Spanish</td><td>INN</td></tr><tr><td>Tobramicina</td><td>Italian</td><td>DCIT</td></tr><tr><td>Tobramycin</td><td>German</td><td>INN</td></tr><tr><td>Tobramycine </td><td>French</td><td>INN</td></tr><tr><td>Tobramycinum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Tobramycin Sulfate</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000317/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000317/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: ZEUUPKVZFKBXPW-TWDWGCDDSA-N</li>
              <li>Monoisotopic Mass: 565.226507049</li>
              <li>Average Mass: 565.593</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000317">DBSALT000317</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Aktob</td><td>Akorn</td></tr><tr><td>Alveoterol</td><td>Tetrafarm</td></tr><tr><td>Amgy</td><td>Kobec</td></tr><tr><td>Bactob</td><td>Solitaire</td></tr><tr><td>Belbarmicina</td><td>Quimica Luar</td></tr><tr><td>BETHKIS</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Bideon Biotic</td><td>Fecofar</td></tr><tr><td>Bioptic</td><td>Bausch &amp; Lomb</td></tr><tr><td>Bramitob</td><td>Torrex</td></tr><tr><td>Gernebcin</td><td>Infectopharm</td></tr><tr><td>Nebcin</td><td>Lilly</td></tr><tr><td>Obracin</td><td>EuroCept</td></tr><tr><td>Tobi</td><td>Novartis</td></tr><tr><td>Tobracin</td><td>Opso Saline</td></tr><tr><td>Tobramaxin</td><td>Alcon</td></tr><tr><td>Tobrex</td><td>Alcon</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Amgydex</td><td>Tobramycin and Dexamethasone</td></tr><tr><td>Antibioptal</td><td>Tobramycin and Phenylephrine</td></tr><tr><td>Bicrinol</td><td>Tobramycin and Dexamethasone</td></tr><tr><td>Bideon Biotic Plus</td><td>Tobramycin and Dexamethasone</td></tr><tr><td>Tobradex</td><td>Tobramycin and Dexamethasone</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/anti-bacterial-agents">Anti-Bacterial Agents</a></li>
<li><a href="/mesh/aminoglycosides">Aminoglycosides</a></li></ul></td></tr><tr><th>CAS number</th><td>32986-56-4</td></tr><tr><th>Weight</th><td>Average: 467.5145<br>Monoisotopic: 467.259127807</td></tr><tr><th>Chemical Formula</th><td>C<sub>18</sub>H<sub>37</sub>N<sub>5</sub>O<sub>9</sub></td></tr><tr><th>InChI Key</th><td>NLVFBUXFDBBNBW-PBSUHMDJSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol</div></td></tr><tr><th>SMILES</th><td><div class="wrap">NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organooxygen Compounds</td></tr><tr><th>Class</th><td>Carbohydrates and Carbohydrate Conjugates</td></tr><tr><th>Subclass</th><td>Amino Sugars</td></tr><tr><th>Direct parent</th><td>Aminocyclitol Glycosides</td></tr><tr><th>Alternative parents</th><td>Dihexoses; O-glycosyl Compounds; Aminocyclitols and Derivatives; Cyclohexanols; Oxanes; 1,2-Aminoalcohols; Primary Alcohols; Polyamines; Acetals; Monoalkylamines</td></tr><tr><th>Substituents</th><td>o-glycosyl compound; glycosyl compound; disaccharide; aminocyclitol derivative; cyclitol derivative; cyclohexanol; oxane; cyclic alcohol; secondary alcohol; 1,2-aminoalcohol; polyamine; acetal; ether; primary alcohol; primary amine; alcohol; organonitrogen compound; amine; primary aliphatic amine</td></tr><tr><th>Classification description</th><td>This compound belongs to the aminocyclitol glycosides. These are organic compounds containing an amicocyclitol moiety glycosidially linked to a carbohydrate moiety.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of pseudomonas aeruginosa lung infections. Also being investigated for use in the treatment of sinus infections.</td></tr><tr><th>Pharmacodynamics</th><td>Tobramycin, an aminoglycoside antibiotic obtained from cultures of <i>Streptomyces tenebrarius</i>, is used in combination with other antibiotics to treat urinary tract infections, gynecologic infections, peritonitis, endocarditis, pneumonia, bacteremia and sepsis, respiratory infections including those associated with cystic fibrosis, osteomyelitis, and diabetic foot and other soft-tissue infections. It acts primarily by disrupting protein synthesis, leading to altered cell membrane permeability, progressive disruption of the cell envelope, and eventual cell death. Tobramycin has in vitro activity against a wide range of gram-negative organisms including <em>Pseudomonas aeruginosa</em>.</td></tr><tr><th>Mechanism of action</th><td>Tobramycin binds irreversibly to one of two aminoglycoside binding sites on the 30 S ribosomal subunit, inhibiting bacterial protein synthesis. Tobramycin may also destabilize bacterial memebrane by binding to 16 S 16 S r-RNA. An active transport mechanism for aminoglycoside uptake is necessary in the bacteria in order to attain a significant intracellular concentration of tobramycin.</td></tr><tr><th>Absorption</th><td>The bioavailability of tobramycin may vary because of individual differences in nebulizer performance and airway pathology.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td>The elimination half-life of tobramycin from serum is approximately 2 hours after intravenous (IV) administration.</td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub>=441mg/kg (s.c. in mice)</td></tr><tr><th>Affected organisms</th><td><ul><li>Enteric bacteria and other eubacteria</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              -
        </td>
        <td>0.9313</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9794</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.759</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.5933</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.7579</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9086</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8412</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8361</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8333</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.6662</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9052</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9359</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.923</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9117</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9728</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9398</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.7537
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9469
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9052
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.7638 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9695
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.7522
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Alcon laboratories inc</li>
<li>Akorn inc</li>
<li>Alcon universal ltd</li>
<li>Altana inc</li>
<li>Bausch and lomb pharmaceuticals inc</li>
<li>Novex pharma</li>
<li>Falcon pharmaceuticals ltd</li>
<li>Novartis pharmaceuticals corp</li>
<li>Eli lilly and co</li>
<li>Akorn strides llc</li>
<li>Apothecon inc div bristol myers squibb</li>
<li>App pharmaceuticals llc</li>
<li>Astrazeneca lp</li>
<li>Baxter healthcare corp anesthesia and critical care</li>
<li>Hospira inc</li>
<li>Marsam pharmaceuticals llc</li>
<li>Teva parenteral medicines inc</li>
<li>X gen pharmaceuticals inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li>Advanced Pharmaceutical Services Inc.</li>
<li><a href="http://www.akorn.com">Akorn Inc.</a></li>
<li><a href="http://www.alcon.com">Alcon Laboratories</a></li>
<li><a href="http://www.apotex.com">Apotex Inc.</a></li>
<li><a href="http://www.apppharma.com">APP Pharmaceuticals</a></li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.bausch.com">Bausch &amp; Lomb Inc.</a></li>
<li><a href="http://www.bms.com">Bristol-Myers Squibb Co.</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li><a href="http://www.phoenixpharm.com">Clipper Distributing Co. LLC</a></li>
<li><a href="http://www.darbydental.com">Darby Dental Supply Co. Inc.</a></li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li>E.R. Squibb and Sons LLC</li>
<li><a href="http://www.eyecareandcure.com">Eye Care and Cure Corp.</a></li>
<li><a href="http://www.falconpharma.com">Falcon Pharmaceuticals Ltd.</a></li>
<li><a href="http://hjharkinscompanyinc.com">H.J. Harkins Co. Inc.</a></li>
<li><a href="http://www.hospira.com">Hospira Inc.</a></li>
<li><a href="http://www.innoviantpharmacy.com">Innoviant Pharmacy Inc.</a></li>
<li><a href="http://www.keltman.com">Keltman Pharmaceuticals Inc.</a></li>
<li>Lake Erie Medical and Surgical Supply</li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li>Medical Ophthalmics</li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.mwivet.com">MWI Veterinary Supply Co.</a></li>
<li><a href="http://www.novartis.com">Novartis AG</a></li>
<li>Novex Pharma</li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li><a href="http://www.ocusoft.com">Ocusoft</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li><a href="http://www.pdrx.com">PD-Rx Pharmaceuticals Inc.</a></li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.preferredpharmaceuticals.com">Preferred Pharmaceuticals Inc.</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Redpharm Drug</li>
<li>Rx Veterinary Products</li>
<li><a href="http://statrxusa.exporterus.com">Stat Rx Usa</a></li>
<li><a href="http://www.stridesarco.com">Strides Arcolab Limited</a></li>
<li>Taylor Pharmaceuticals</li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li><a href="http://www.vedco.com">Vedco Inc.</a></li>
<li><a href="http://www.hilco.com">Wilson Ophthalmic Corp.</a></li>
<li><a href="http://www.x-gen.us">X-Gen Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Liquid</td><td>Intravenous</td><td></td></tr><tr><td>Liquid</td><td>Ophthalmic</td><td></td></tr><tr><td>Ointment</td><td>Ophthalmic</td><td></td></tr><tr><td>Powder, for solution</td><td>Intravenous</td><td></td></tr><tr><td>Solution</td><td>Ophthalmic</td><td></td></tr><tr><td>Solution</td><td>Respiratory (inhalation)</td><td></td></tr></tbody></table></td></tr><tr><th>Prices</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="prices"><thead><tr><th>Unit description</th><th>Cost</th><th>Unit</th></tr></thead><tbody><tr><td>Tobi (1 Box = 56, 5ml Ampules = 280ml Total) 280ml Plastic Container</td><td>4461.42USD</td><td>plastic</td></tr><tr><td>Tobramycin 1.2 gm vial</td><td>338.25USD</td><td>vial</td></tr><tr><td>TobraDex 0.3-0.1% Suspension 10ml Bottle</td><td>200.43USD</td><td>bottle</td></tr><tr><td>TobraDex 0.3-0.1% Ointment 3.5 gm Tube</td><td>126.67USD</td><td>tube</td></tr><tr><td>TobraDex 0.3-0.1% Suspension 5ml Bottle</td><td>98.11USD</td><td>bottle</td></tr><tr><td>Tobrex 0.3% Ointment 3.5 gm Tube</td><td>80.02USD</td><td>tube</td></tr><tr><td>Tobrex 0.3% Solution 5ml Bottle</td><td>67.58USD</td><td>bottle</td></tr><tr><td>TobraDex 0.3-0.1% Suspension 2.5ml Bottle</td><td>54.99USD</td><td>bottle</td></tr><tr><td>Tobramycin sulfate powder</td><td>53.55USD</td><td>g</td></tr><tr><td>Tobradex eye drops</td><td>19.27USD</td><td>ml</td></tr><tr><td>Tobi 300 mg/5 ml solution</td><td>17.58USD</td><td>ml</td></tr><tr><td>Tobramycin Sulfate 0.3% Solution 5ml Bottle</td><td>15.99USD</td><td>bottle</td></tr><tr><td>Tobrex 0.3% eye drops</td><td>13.0USD</td><td>ml</td></tr><tr><td>Tobi 60 mg/ml Solution</td><td>11.4USD</td><td>ml</td></tr><tr><td>Tobramycin Sulfate 40 mg/ml Solution</td><td>3.6USD</td><td>ml</td></tr><tr><td>Tobramycin 40 mg/ml</td><td>3.14USD</td><td>ml</td></tr><tr><td>Tobramycin 0.3% eye drops</td><td>2.99USD</td><td>ml</td></tr><tr><td>Aktob 0.3% eye drops</td><td>2.85USD</td><td>ml</td></tr><tr><td>Tobrex 0.3 % Ointment</td><td>2.66USD</td><td>g</td></tr><tr><td>Tobramycin 10 mg/ml</td><td>2.26USD</td><td>ml</td></tr><tr><td>Tobrex 0.3 % Solution</td><td>1.88USD</td><td>ml</td></tr><tr><td>Pms-Tobramycin 0.3 % Solution</td><td>1.05USD</td><td>ml</td></tr><tr><td>Sandoz Tobramycin 0.3 % Solution</td><td>1.05USD</td><td>ml</td></tr><tr><td>Tobramycin 60 mg/50 ml ns</td><td>0.19USD</td><td>ml</td></tr></tbody></table><div class="alert alert-warning clearfix">DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.</div></td></tr><tr><th>Patents</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="patents"><thead><tr><th>Country</th><th>Patent Number</th><th>Approved</th><th>Expires (estimated)</th></tr></thead><tbody><tr><td>United States</td><td>5508269</td><td>1994-10-19</td><td>2014-10-19</td></tr><tr><td>United States</td><td>5149694</td><td>1992-09-22</td><td>2009-09-22</td></tr><tr><td>Canada</td><td>2414737</td><td>2009-01-06</td><td>2021-06-26</td></tr></tbody></table></td></tr><tr id="properties"><th class="divider" colspan="2">Properties</th></tr><tr><th>State</th><td>solid</td></tr><tr><th>Experimental Properties</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr><tr><td>water solubility</td><td>1E+003 mg/ml</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>logP</td><td>-5.8</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></table></td></tr><tr><th>Predicted Properties</th><td class="data-table-container"><table class="table table-condensed table-striped"><thead><tr><th class="head-medium">Property</th><th class="head-large">Value</th><th>Source</th></tr></thead><tbody><tr><td>water solubility</td><td>5.37e+01 g/l</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-3</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>logP</td><td>-6.5</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#logp_logd">ChemAxon</a></td></tr><tr><td>logS</td><td>-0.94</td><td><a href="http://www.vcclab.org/lab/alogps/" target="_blank">ALOGPS</a></td></tr><tr><td>pKa (strongest acidic)</td><td>12.54</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>pKa (strongest basic)</td><td>9.83</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>physiological charge</td><td>5</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-predictors/#pka">ChemAxon</a></td></tr><tr><td>hydrogen acceptor count</td><td>14</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>hydrogen donor count</td><td>10</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#h_bond">ChemAxon</a></td></tr><tr><td>polar surface area</td><td>268.17</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topolgical_surface">ChemAxon</a></td></tr><tr><td>rotatable bond count</td><td>6</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>refractivity</td><td>106.69</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#refractivity">ChemAxon</a></td></tr><tr><td>polarizability</td><td>47.18</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>number of rings</td><td>3</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/property-calculations/#topology_analysis">ChemAxon</a></td></tr><tr><td>bioavailability</td><td>0</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>rule of five</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Ghose filter</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>Veber's rule</td><td>No</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr><tr><td>MDDR-like rule</td><td>Yes</td><td><a href="http://www.chemaxon.com/products/calculator-plugins/molecular-modelling/#polarization">ChemAxon</a></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="references"><th class="divider" colspan="2">References</th></tr><tr><th>Synthesis Reference</th><td><span class="citations"><p>Istvan Bakondi-Kovacs, &#8220;Metabolic controlled fermentation process for carbamoyl tobramycin production.&#8221; U.S. Patent US20020197683, issued December 26, 2002.</p></span><a class="wishart-link-out" href="https://www.google.com/?tbm=pts#q=20020197683&amp;tbm=pts" target="_blank">US20020197683 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><th>General Reference</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>External Links</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Resource</th><th>Link</th></tr></thead><tbody><tr><td>KEGG Drug</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?drug:D00063" target="_blank">D00063 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>KEGG Compound</td><td><a class="wishart-link-out" href="http://www.genome.jp/dbget-bin/www_bget?cpd:C00397" target="_blank">C00397 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Compound</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=36294" target="_blank">36294 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PubChem Substance</td><td><a class="wishart-link-out" href="http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46507662" target="_blank">46507662 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChemSpider</td><td><a class="wishart-link-out" href="http://www.chemspider.com/Chemical-Structure.33377.html" target="_blank">33377 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>BindingDB</td><td><a class="wishart-link-out" href="http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50090265" target="_blank">50090265 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEBI</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chebi/searchId.do?chebiId=28864" target="_blank">28864 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>ChEMBL</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1747" target="_blank">CHEMBL1747 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Therapeutic Targets Database</td><td><a class="wishart-link-out" href="http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000110" target="_blank">DAP000110 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>PharmGKB</td><td><a class="wishart-link-out" href="http://www.pharmgkb.org/drug/PA451704" target="_blank">PA451704 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>HET</td><td><a class="wishart-link-out" href="http://www.ebi.ac.uk/msd-srv/chempdb/cgi-bin/cgi.pl?FUNCTION=getByCode&amp;CODE=TOY" target="_blank">TOY <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drug Product Database</td><td><a class="wishart-link-out" href="http://205.193.93.51/dpdonline/searchRequest.do?din=2241209" target="_blank">2241209 <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>RxList</td><td><a class="wishart-link-out" href="http://www.rxlist.com/cgi/generic/tobi.htm" target="_blank">http://www.rxlist.com/cgi/generic/tobi.htm <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Drugs.com</td><td><a class="wishart-link-out" href="http://www.drugs.com/cdi/tobramycin-drops.html" target="_blank">http://www.drugs.com/cdi/tobramycin-drops.html <span class="glyphicon glyphicon-new-window"> </span></a></td></tr><tr><td>Wikipedia</td><td><a class="wishart-link-out" href="http://en.wikipedia.org/wiki/Tobramycin" target="_blank">Tobramycin <span class="glyphicon glyphicon-new-window"> </span></a></td></tr></tbody></table></td></tr><tr><th>ATC Codes</th><td>J01GB01<ul class="atc-drug-tree"><li><a href="/atc/J#J">J &#8212; ANTIINFECTIVES FOR SYSTEMIC USE</a></li><li><a href="/atc/J01#J01">J01 &#8212; ANTIBACTERIALS FOR SYSTEMIC USE</a></li><li><a href="/atc/J01G#J01G">J01G &#8212; AMINOGLYCOSIDE ANTIBACTERIALS</a></li><li><a href="/atc/J01GB#J01GB">J01GB &#8212; Other aminoglycosides</a></li></ul>S01AA12<ul class="atc-drug-tree"><li><a href="/atc/S#S">S &#8212; SENSORY ORGANS</a></li><li><a href="/atc/S01#S01">S01 &#8212; OPHTHALMOLOGICALS</a></li><li><a href="/atc/S01A#S01A">S01A &#8212; ANTIINFECTIVES</a></li><li><a href="/atc/S01AA#S01AA">S01AA &#8212; Antibiotics</a></li></ul></td></tr><tr><th>AHFS Codes</th><td><ul><li>52:04.04</li>
<li>08:12.02</li></ul></td></tr><tr><th>PDB Entries</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>FDA label</th><td><a href="/system/fda_labels/DB00684.pdf?1265922807">show</a>(414 KB)</td></tr><tr><th>MSDS</th><td><a href="/system/msds/DB00684.pdf?1265922745">show</a>(73.3 KB)</td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00819">Acetazolamide</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00681">Amphotericin B</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00732">Atracurium</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00542">Benazepril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00887">Bumetanide</a></td><td>Increased ototoxicity</td></tr><tr><td><a href="/drugs/DB00796">Candesartan</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01197">Captopril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01326">Cefamandole</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01139">Cefapirin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01327">Cefazolin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01328">Cefonicid</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01329">Cefoperazone</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00923">Ceforanide</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00493">Cefotaxime</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01330">Cefotetan</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01331">Cefoxitin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01333">Cefradine</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00438">Ceftazidime</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01332">Ceftizoxime</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01212">Ceftriaxone</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01112">Cefuroxime</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB03450">Cephalothin Group</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00515">Cisplatin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01111">Colistimethate</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00900">Didanosine</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01135">Doxacurium chloride</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00584">Enalapril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00903">Ethacrynic acid</a></td><td>Increased ototoxicity</td></tr><tr><td><a href="/drugs/DB00492">Fosinopril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00695">Furosemide</a></td><td>Increased ototoxicity</td></tr><tr><td><a href="/drugs/DB01109">Heparin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01029">Irbesartan</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00709">Lamivudine</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00722">Lisinopril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01356">Lithium</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00678">Losartan</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01336">Metocurine</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01226">Mivacurium</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00275">Olmesartan</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01337">Pancuronium</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00790">Perindopril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00252">Phenytoin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01338">Pipecuronium</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00881">Quinapril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00178">Ramipril</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00728">Rocuronium</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00421">Spironolactone</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00202">Succinylcholine</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB01015">Sulfamethoxazole</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00864">Tacrolimus</a></td><td>Additive renal impairment may occur during concomitant therapy with aminoglycosides such as Tobramycin. Use caution during concomitant therapy.</td></tr><tr><td><a href="/drugs/DB00966">Telmisartan</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01041">Thalidomide</a></td><td>Thalidomide increases the renal toxicity of the aminoglycoside</td></tr><tr><td><a href="/drugs/DB01607">Ticarcillin</a></td><td>Ticarcillin may reduce the serum concentration of Tobramycin. Ticarcillin may inactivate Tobramycin in vitro and the two agents should not be administered simultaneously through the same IV line.</td></tr><tr><td><a href="/drugs/DB00273">Topiramate</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00214">Torasemide</a></td><td>Increased ototoxicity</td></tr><tr><td><a href="/drugs/DB00440">Trimethoprim</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01199">Tubocurarine</a></td><td>The agent increases the effect of the muscle relaxant</td></tr><tr><td><a href="/drugs/DB00177">Valsartan</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB00512">Vancomycin</a></td><td>Increased risk of nephrotoxicity</td></tr><tr><td><a href="/drugs/DB01339">Vecuronium</a></td><td>The agent increases the effect of the muscle relaxant</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>